These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33738351)

  • 21. Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight.
    Nalluri N; Patel N; Saouma S; Anugu VR; Anugula D; Asti D; Mehta V; Kumar V; Atti V; Edla S; Grewal RK; Khan HM; Kanotra R; Maniatis G; Kandov R; Lafferty JC; Dyal M; Alfonso CE; Cohen MG
    Expert Rev Med Devices; 2017 Oct; 14(10):789-804. PubMed ID: 28862481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock.
    Kuchibhotla S; Esposito ML; Breton C; Pedicini R; Mullin A; O'Kelly R; Anderson M; Morris DL; Batsides G; Ramzy D; Grise M; Pham DT; Kapur NK
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiogenic shock secondary to severe acute ischemic mitral regurgitation managed with an Impella 2.5 percutaneous left ventricular assist device.
    Harmon L; Boccalandro F
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1129-34. PubMed ID: 21805597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
    Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle.
    Josiassen J; Helgestad OKL; Udesen NLJ; Banke A; Frederiksen PH; Hyldebrandt JA; Schmidt H; Jensen LO; Hassager C; Ravn HB; Møller JE
    Intensive Care Med Exp; 2020 Aug; 8(1):41. PubMed ID: 32785808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impella percutaneous left ventricular assist device for severe acute ischaemic mitral regurgitation as a bridge to surgery.
    Jalil B; El-Kersh K; Frizzell J; Ahmed S
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous biventricular Impella support in therapy-refractory cardiogenic shock.
    Chiu CY; Hättasch R; Praeger D; Knebel F; Stangl K; Ramirez ID; Dreger H
    Heart Lung; 2018; 47(3):250-252. PubMed ID: 29628145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute mitral regurgitation: unforeseen new complication of the Impella LP 5.0 ventricular assist device and review of literature.
    Elhussein TA; Hutchison SJ
    Heart Lung Circ; 2014 Mar; 23(3):e100-4. PubMed ID: 24296306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery.
    Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I
    J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined hemodynamic support with the Impella 2.5 device and intra-aortic balloon pump for management of refractory cardiogenic shock.
    Pavlidis AN; Redwood SR; Clapp BR
    J Invasive Cardiol; 2014 May; 26(5):E50-1. PubMed ID: 24791724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients.
    Schäfer A; Werner N; Burkhoff D; Sieweke JT; Zietzer A; Masyuk M; Junker Udesen NL; Westenfeld R; Møller JE
    Front Cardiovasc Med; 2020; 7():74. PubMed ID: 32478095
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data.
    Wernly B; Seelmaier C; Leistner D; Stähli BE; Pretsch I; Lichtenauer M; Jung C; Hoppe UC; Landmesser U; Thiele H; Lauten A
    Clin Res Cardiol; 2019 Nov; 108(11):1249-1257. PubMed ID: 30900010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bridge to durable left ventricular assist device for refractory cardiogenic shock.
    Yoshioka D; Takayama H; Garan AR; Topkara VK; Han J; Li B; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    J Thorac Cardiovasc Surg; 2017 Apr; 153(4):752-762.e5. PubMed ID: 27988030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impella-Induced Incessant Ventricular Tachycardia.
    Kaki A; Subahi A; Shokr M; Ibrahim W; Yassin A; Hasan R; Alraies MC; Schreiber T
    Ochsner J; 2019; 19(3):248-251. PubMed ID: 31528136
    [No Abstract]   [Full Text] [Related]  

  • 39. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature.
    Cubeddu RJ; Lago R; Horvath SA; Vignola PA; O'Neill W; Palacios IF
    EuroIntervention; 2012 Apr; 7(12):1453-60. PubMed ID: 22522555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.